Competing interests
L.B. reports speaker’s bureau for AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Fresenius Kabi, Janssen, MSD, Novartis, Organon, Pfizer, Sandoz, Sanofi, Teva, and UCB; consulting for AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Fresenius Kabi, Gilead, Janssen, MSD, Novartis, Organon, Pfizer, Sandoz, Sanofi, Teva, and UCB; grant/research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, MSD, Novartis, Pfizer, Sanofi, and UCB.B.H. reports consulting for and/or grant support from Abbvie, Amgen, Eli Lilly, Pfizer and UCB.E.R. and J.D. are employees of JSS Medical Research.M–O. T. is an employee of Bristol Myers Squibb and may hold stock or stock options.J.P. reports grant/research support from AbbVie, Bristol Myers Squibb, MSD, Pfizer, Roche, Seattle Genetics, UCB; consulting for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Gilead, Janssen, Medexus, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, Teva and UCB.